• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MyungMoon Pharm Co Ltd

+ Add to Watchlist

017180:KS

2,465 KRW 15 0.61%

As of 01:16:01 ET on 12/19/2014.

Snapshot for MyungMoon Pharm Co Ltd (017180)

Open: 2,450 Day's Range: 2,440 - 2,495 Volume: 42,215
Previous Close: 2,450 52wk Range: 2,068 - 3,185 1-Yr Rtn: +19.53%

Stock Chart for 017180

No chart data available.
  • 017180:KS 2,465
  • 1D
  • 1M
  • 1Y
2,450
Interactive 017180 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 017180

Current P/E Ratio (ttm) 39.2242
Estimated P/E(-) -
Relative P/E vs. KOSPI 1.2570
Earnings Per Share (ttm) 62.8438
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 43,162.15
Shares Outstanding (M) 17.51
30 Day Average Volume 109,473
Price/Book (mrq) 0.5894
Price/Sale (ttm) 0.3892
Dividend Indicated Gross Yield 0.73%
Cash Dividend (KRW) 18.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -16.23%
Next Earnings Announcement 02/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 017180

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 017180

Myungmoon Pharm. Co., Ltd. manufactures a variety of pharmaceutical products. The Company's major products include anesthetics, digestive, antitussive, and antibiotics.

Lee Kyu-HyukChairman/CEO/Co-Rep DirectorWoo Seok-MinPresident/Co-Rep Director
Bae Chul-HanVice PresidentPark Choon-SikSenior Managing Director
More Company Profile & Key Executives for 017180

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil